K
Kyverna Therapeutics Inc
NASDAQ:KYTX
Kyverna Therapeutics Inc
NASDAQ:KYTX
Price:
8.39
USD
-5.41%
Market Cap:
$479.3m
Income Statement
Earnings Waterfall
Kyverna Therapeutics Inc
Kyverna Therapeutics Inc
Income Statement
Kyverna Therapeutics Inc
Kyverna Therapeutics Inc
Currency:
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(62)
|
(91)
|
(124)
|
(122)
|
(143)
|
(160)
|
(172)
|
(172)
|
|
| Selling, General & Administrative |
(12)
|
(19)
|
(25)
|
(27)
|
(30)
|
(33)
|
(36)
|
(34)
|
|
| Research & Development |
(50)
|
(72)
|
(100)
|
(96)
|
0
|
(127)
|
(136)
|
(137)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
(113)
|
0
|
0
|
0
|
|
| Operating Income |
(62)
N/A
|
(91)
-46%
|
(124)
-36%
|
(122)
+2%
|
(143)
-17%
|
(160)
-12%
|
(172)
-7%
|
(172)
+0%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
2
|
5
|
9
|
12
|
0
|
15
|
13
|
11
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
16
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(60)
N/A
|
(87)
-45%
|
(116)
-33%
|
(111)
+4%
|
(127)
-14%
|
(146)
-15%
|
(159)
-9%
|
(161)
-1%
|
|
| Net Income | |||||||||
| Income from Continuing Operations |
(60)
|
(87)
|
(116)
|
(111)
|
(127)
|
(146)
|
(159)
|
(161)
|
|
| Net Income (Common) |
(60)
N/A
|
(87)
-45%
|
(116)
-33%
|
(111)
+4%
|
(127)
-14%
|
(146)
-15%
|
(159)
-9%
|
(161)
-1%
|
|
| EPS (Diluted) |
-1.4
N/A
|
-2.03
-45%
|
-2.7
-33%
|
-2.57
+5%
|
-3.33
-30%
|
-3.37
-1%
|
-3.67
-9%
|
-3.72
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
